Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 500 (RNA5SP500) is a human pseudogene that shares sequence similarity with functional 5S ribosomal RNA genes but does not encode a functional RNA product[2]. 5S rRNA is normally a structural and functional component of the large ribosomal subunit, essential for ribosome assembly and protein synthesis in active genes[1][3]. In contrast, pseudogenes like RNA5SP500 are generally nonfunctional due to accumulated mutations, do not participate in biological pathways, and are not therapeutic targets or disease-associated entities[2][4]. No drug interactions, biomarker roles, or safety concerns are known or relevant for this pseudogene. This entry is likely to be “incorrect” as a therapeutic target because it is a pseudogene: it is not expressed as a functional RNA and has no known biological, pharmacological, or disease relevance[2][4]. Pseudogenes are considered genomic relics rather than protein-coding genes or regulatory RNAs, and are not considered valid targets for drug discovery or clinical intervention[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 500 (RNA5SP500).